MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...

Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...

Sept 29 (Reuters) - Alliance Laundry is targeting a valuation of up to $4.34 billion in its U.S. initial public offering, the commercial laundry equipment maker said on Monday, as the frenzy around ...

Artificial Intelligence (AI) is now a major force in the U.S. economy. The rapid expansion of data centers in the United States has emphasized the challenges facing the U.S. electricity sector, which ...

The dynamic, innovative, and agile environment that is the pharmaceutical industry requires a particular set of skills. For MSD Ireland, one of the country’s largest healthcare companies with eight ...

PEMBROKE PINES, FLORIDA - MAY 16: High voltage power lines run along the electrical power grid on May 16, 2024, in Pembroke Pines, Florida. The grid is strained by increasing demand from ...

Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...